Our organization was established in 1996 for the purpose of developing an affordable and effective immune-system based treatment for AIDS and other immune system disorders, such as autoimmune diseases (lupus, rheumatoid arthritis, ulcerative colitis, ALS, and more). We want to make this future drug available to the people who need it in a timely and cost-effective manner.